Cargando…

Severity of COVID-19 infection in prostate cancer patients and effect of ADT on disease presentation

Detalles Bibliográficos
Autores principales:	García Fuentes, C., Jiménez Alcaide, E., Hernández, V., De La Pena Zarzuelo, E., Guijarro Cascales, A., Castro Fajardo, A., Pérez-Fernández, E., Llorente, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. Published by Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263116/ http://dx.doi.org/10.1016/S0302-2838(21)01223-9

Ejemplares similares

ADT and OBSBOX in 2016
por: Valuch, D, et al.
Publicado: (2017)

Transport of ADT
por: Juha Sakkinen
Publicado: (2006)

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration‐resistant prostate cancer: AFTERCAB study
por: Uemura, Hiroji, et al.
Publicado: (2021)

ADT fast losses MD
por: Priebe, A, et al.
Publicado: (2013)

The effect of strength training on muscle cellular stress in prostate cancer patients on ADT
por: Nilsen, T S, et al.
Publicado: (2016)

The impact of hegemonic masculine ideals on self‐esteem in prostate cancer patients undergoing androgen deprivation therapy (ADT) compared to ADT‐naïve patients
por: Gentili, Caterina, et al.
Publicado: (2022)

ADT and RF after LS1
por: Butterworth, A, et al.
Publicado: (2015)

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer
por: Newton, Robert U., et al.
Publicado: (2020)

Weniger Corona-Infektionen unter ADT?
por: Bublak, Robert
Publicado: (2020)

Bridging Arrays and ADTs in Recursive Proofs
por: Fedyukovich, Grigory, et al.
Publicado: (2021)

Efficacy and Safety of Combined Androgen Deprivation Therapy (ADT) and Docetaxel Compared with ADT Alone for Metastatic Hormone-Naive Prostate Cancer: A Systematic Review and Meta-Analysis
por: Botrel, Tobias Engel Ayer, et al.
Publicado: (2016)

Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
por: Mahalingam, Devalingam, et al.
Publicado: (2023)

International survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Liede, Alexander, et al.
Publicado: (2016)

Correction: Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized phase II study of metformin in non-diabetic men initiating ADT for advanced prostate cancer
por: Mahalingam, Devalingam, et al.
Publicado: (2023)

Adjusting the duration of androgen deprivation therapy (ADT) based on nadir PSA for high risk localized prostate cancer patients treated with definitive external beam radiation therapy and ADT
por: Ayoub, Zeina, et al.
Publicado: (2022)

The LHC Transverse Damper (ADT) Performance Specification
por: Boussard, Daniel, et al.
Publicado: (2000)

The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
por: Lawrenson, Ross, et al.
Publicado: (2014)

Genomic Prostate Score: A New Tool to Assess Prognosis and Optimize Radiation Therapy Volumes and ADT in Intermediate-Risk Prostate Cancer
por: Belkacemi, Yazid, et al.
Publicado: (2023)

Noise studies with new ADT pickups (MD4143)
por: Buffat, Xavier, et al.
Publicado: (2019)

Myokine Expression and Tumor-Suppressive Effect of Serum after 12 wk of Exercise in Prostate Cancer Patients on ADT
por: KIM, JIN-SOO, et al.
Publicado: (2022)

Editorial on an international survey of androgen deprivation therapy (ADT) for non-metastatic prostate cancer in 19 countries
por: Sternberg, Cora N
Publicado: (2016)

Biochemical recurrence related metabolic novel signature associates with immunity and ADT treatment responses in prostate cancer
por: Wang, Xuan, et al.
Publicado: (2022)

Emittance growth in collision with optimised ADT settings (MD3291)
por: Buffat, Xavier, et al.
Publicado: (2019)

Active halo control through narrow-band excitation with the ADT
por: Wagner, Joschka, et al.
Publicado: (2016)

ADT and Obsbox in LHC Run 2, Plans for LS2
por: Söderén, M, et al.
Publicado: (2019)

AB17. ADT treatment promotes PCa EMT and metastasis
por: Niu, Yuan-Jie
Publicado: (2014)

Palliative TURP Combined with Intermittent ADT Is A Curative Therapy to Some Elderly Men with Localized Prostate Adenocarcinoma
por: Zhang, Xu, et al.
Publicado: (2023)

Improving Diabetes Care via Telemedicine: Lessons From the Addressing Diabetes in Tennessee (ADT) Project
por: Nyenwe, Ebenezer A., et al.
Publicado: (2011)

Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
por: Chowdhury, Simon, et al.
Publicado: (2019)

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer
por: Nguyen, P L, et al.
Publicado: (2017)

Hypothalamic connectivities predict individual differences in ADT-elicited changes in working memory and quality of life in prostate cancer patients
por: Chaudhary, Shefali, et al.
Publicado: (2022)

Does ADT Influence the Risk of Suicidal Ideation among US Veteran Prostate Cancer Patients Pre-Exposed to PTSD?
por: Brahmbhatt, Smit, et al.
Publicado: (2023)

Influence of ADT on B7-H3 expression during CRPC progression from hormone-naïve prostate cancer
por: Kang, Ning, et al.
Publicado: (2023)

MD4036: New ADT signal processing for large tune acceptance
por: Komppula, Jani Paavo Olavi, et al.
Publicado: (2019)

FedADT: An Adaptive Method Based on Derivative Term for Federated Learning
por: Gao, Huimin, et al.
Publicado: (2023)

Efficacy and safety of Androgen Deprivation Therapy (ADT) combined with modified docetaxel chemotherapy versus ADT combined with standard docetaxel chemotherapy in patients with metastatic castration-resistant prostate cancer: study protocol for a multicentre prospective randomized controlled trial
por: Yang, Xiangwei, et al.
Publicado: (2022)

Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration
por: Long, Xingbo, et al.
Publicado: (2020)

Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT
por: Handy, Whitney F., et al.
Publicado: (2020)

Targeting ADT-Induced Activation of the E3 Ubiquitin Ligase Siah2 to Delay the Occurrence of Castration-Resistant Prostate Cancer
por: Yan, Tingmang, et al.
Publicado: (2021)

Impact of the ADT on the beam quality with high brightness beams in collision (MD2155)
por: Buffat, Xavier, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_72rebh5sjg07d1fa65hnf850lc